In partnership with Microsoft’s Cloud for Healthcare and Clinical Research Innovation Hub, EPAM’s Digital Clinical Trial (DCT) accelerator offers a modularized approach of implementing technical accelerators in the areas of e-Consent, Telehealth, ePRO/eCOA Mobile configuration, as well as IoT integration.

By leveraging Microsoft’s Azure platform and its suite of highly configurable products, EPAM’s DCT accelerator provides Life Science companies with the ability to evolve their current state past a traditional clinical trial model, and into a future state that allows for increased patient and clinician collaboration, as well as access and monitoring of patient data in a remote capacity.

The goal, ultimately, being to ensure the eligibility of a more diverse subject population, an improved trial experience, increased ownership and access to data, as well as the reduction of trial timelines and cost at the site and sponsor levels.